应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CHRS Coherus Biosciences
休市中 02-28 16:00:00 EST
1.11
+0.03
+2.78%
盘后
1.13
+0.02
+1.80%
19:41 EST
最高
1.14
最低
1.06
成交量
120.90万
今开
1.08
昨收
1.08
日振幅
7.87%
总市值
1.28亿
流通市值
1.26亿
总股本
1.15亿
成交额
133.86万
换手率
1.06%
流通股本
1.14亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Coherus Biosciences, Inc.盘中异动 快速拉升5.09%
市场透视 · 02-28 15:32
Coherus Biosciences, Inc.盘中异动 快速拉升5.09%
Coherus Biosciences, Inc.盘中异动 临近午盘股价大涨5.14%
市场透视 · 02-24
Coherus Biosciences, Inc.盘中异动 临近午盘股价大涨5.14%
Coherus Biosciences, Inc.盘中异动 早盘急速跳水5.36%
市场透视 · 02-19
Coherus Biosciences, Inc.盘中异动 早盘急速跳水5.36%
Coherus Biosciences, Inc.盘中异动 大幅下跌5.00%
市场透视 · 02-18
Coherus Biosciences, Inc.盘中异动 大幅下跌5.00%
Coherus Biosciences, Inc.盘中异动 下午盘大幅下挫5.13%报1.11美元
市场透视 · 02-11
Coherus Biosciences, Inc.盘中异动 下午盘大幅下挫5.13%报1.11美元
Coherus Biosciences, Inc.盘中异动 大幅拉升5.36%
市场透视 · 02-10
Coherus Biosciences, Inc.盘中异动 大幅拉升5.36%
Coherus Biosciences, Inc.盘中异动 急速下跌5.00%
市场透视 · 02-06
Coherus Biosciences, Inc.盘中异动 急速下跌5.00%
Coherus Biosciences, Inc.盘中异动 早盘大幅拉升5.17%
市场透视 · 02-05
Coherus Biosciences, Inc.盘中异动 早盘大幅拉升5.17%
Coherus Biosciences, Inc.盘中异动 急速拉升5.41%
市场透视 · 02-04
Coherus Biosciences, Inc.盘中异动 急速拉升5.41%
Coherus Biosciences, Inc.盘中异动 股价大跌5.17%
市场透视 · 01-31
Coherus Biosciences, Inc.盘中异动 股价大跌5.17%
Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.34%报1.29美元
市场透视 · 01-30
Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.34%报1.29美元
Coherus Biosciences, Inc.盘中异动 早盘股价大跌6.47%
市场透视 · 01-28
Coherus Biosciences, Inc.盘中异动 早盘股价大跌6.47%
Coherus Biosciences, Inc.盘中异动 下午盘急速跳水5.24%报1.18美元
市场透视 · 01-27
Coherus Biosciences, Inc.盘中异动 下午盘急速跳水5.24%报1.18美元
Coherus Biosciences, Inc.盘中异动 股价大涨5.08%报1.35美元
市场透视 · 01-24
Coherus Biosciences, Inc.盘中异动 股价大涨5.08%报1.35美元
Coherus Biosciences, Inc.盘中异动 早盘股价大涨6.89%
市场透视 · 01-22
Coherus Biosciences, Inc.盘中异动 早盘股价大涨6.89%
Coherus Biosciences, Inc.盘中异动 股价大跌5.04%
市场透视 · 01-21
Coherus Biosciences, Inc.盘中异动 股价大跌5.04%
Coherus Biosciences, Inc.盘中异动 股价大跌5.14%
市场透视 · 01-16
Coherus Biosciences, Inc.盘中异动 股价大跌5.14%
Coherus Biosciences, Inc.盘中异动 早盘大幅拉升5.56%报1.52美元
市场透视 · 01-15
Coherus Biosciences, Inc.盘中异动 早盘大幅拉升5.56%报1.52美元
Coherus Biosciences, Inc.盘中异动 快速上涨5.44%
市场透视 · 01-14
Coherus Biosciences, Inc.盘中异动 快速上涨5.44%
Coherus Biosciences, Inc.盘中异动 早盘大幅上涨5.10%
市场透视 · 01-08
Coherus Biosciences, Inc.盘中异动 早盘大幅上涨5.10%
加载更多
公司概况
公司名称:
Coherus Biosciences
所属市场:
NASDAQ
上市日期:
--
主营业务:
Coherus Biosciences, Inc.于2010年9月在特拉华州注册成立。该公司是一家商业阶段的生物制药公司,专注于创新癌症治疗的研究、开发和商业化以及已获批准的生物类似物组合的商业化。该公司的战略是建立一个领先的免疫肿瘤专营权,其资金来自通过净销售美国食品和药物管理局批准的疗法的多元化组合所产生的现金。
发行价格:
--
{"stockData":{"symbol":"CHRS","market":"US","secType":"STK","nameCN":"Coherus Biosciences","latestPrice":1.11,"timestamp":1740776400000,"preClose":1.08,"halted":0,"volume":1209021,"hourTrading":{"tag":"盘后","latestPrice":1.13,"preClose":1.11,"latestTime":"19:41 EST","volume":6066,"amount":6748.31,"timestamp":1740789663799},"delay":0,"floatShares":113730172,"shares":115213407,"eps":-0.003959,"marketStatus":"休市中","change":0.03,"latestTime":"02-28 16:00:00 EST","open":1.08,"high":1.14,"low":1.055,"amount":1338600.122815,"amplitude":0.078704,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.003959,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1740992400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1415250000000,"exchange":"NASDAQ","adjPreClose":1.08,"preHourTrading":{"tag":"盘前","latestPrice":1.08,"preClose":1.08,"latestTime":"09:14 EST","volume":692,"amount":758.233188,"timestamp":1740752099891},"postHourTrading":{"tag":"盘后","latestPrice":1.13,"preClose":1.11,"latestTime":"19:41 EST","volume":6066,"amount":6748.31,"timestamp":1740789663799},"volumeRatio":0.9971669354410508,"impliedVol":2.2763,"impliedVolPercentile":0.8008},"requestUrl":"/m/hq/s/CHRS","defaultTab":"news","newsList":[{"id":"2514750043","title":"Coherus Biosciences, Inc.盘中异动 快速拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514750043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514750043?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:32","pubTimestamp":1740756734,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时32分,Coherus Biosciences, Inc.股票出现波动,股价快速拉升5.09%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233214989687b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233214989687b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2514987776","title":"Coherus Biosciences, Inc.盘中异动 临近午盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514987776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514987776?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:36","pubTimestamp":1740414967,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时36分,Coherus Biosciences, Inc.股票出现波动,股价急速上涨5.14%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。该公司在美国销售 Neulasta 的生物仿制药,UDENYCA,并预计于 2023 年在美国推出 FDA 批准的 Humira 生物仿制药 YUSIMRY。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225003608962eb475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225003608962eb475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2512810254","title":"Coherus Biosciences, Inc.盘中异动 早盘急速跳水5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512810254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512810254?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:05","pubTimestamp":1739981106,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时05分,Coherus Biosciences, Inc.股票出现异动,股价大幅下挫5.36%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.47%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000506a24c0d6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000506a24c0d6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2512931101","title":"Coherus Biosciences, Inc.盘中异动 大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512931101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512931101?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:10","pubTimestamp":1739902251,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时10分,Coherus Biosciences, Inc.股票出现异动,股价大幅下挫5.00%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.58%。其相关个股中,Aditxt, Inc.、Solid Biosciences Inc.、Allogene Therapeutics, Inc.涨幅较大,Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃,换手率分别为652.29%、197.44%、164.02%,振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.,振幅分别为148.75%、92.00%、79.17%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021051a24adaa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021051a24adaa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2510532973","title":"Coherus Biosciences, Inc.盘中异动 下午盘大幅下挫5.13%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510532973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510532973?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:32","pubTimestamp":1739298734,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日02时32分,Coherus Biosciences, Inc.股票出现异动,股价急速下挫5.13%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.79%。其相关个股中,Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为3092.34%、1432.04%、482.65%,振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.,振幅分别为143.33%、72.23%、58.60%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212023214a2422ead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212023214a2422ead&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2510089496","title":"Coherus Biosciences, Inc.盘中异动 大幅拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510089496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510089496?lang=zh_cn&edition=full","pubTime":"2025-02-11 03:56","pubTimestamp":1739217413,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日03时56分,Coherus Biosciences, Inc.股票出现异动,股价大幅上涨5.36%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.97%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211035653abc9ea01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211035653abc9ea01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2509789794","title":"Coherus Biosciences, Inc.盘中异动 急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509789794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509789794?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:54","pubTimestamp":1738875267,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时54分,Coherus Biosciences, Inc.股票出现异动,股价快速下跌5.00%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.57%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045427961a4ff7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045427961a4ff7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2509906287","title":"Coherus Biosciences, Inc.盘中异动 早盘大幅拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509906287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509906287?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:02","pubTimestamp":1738767742,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时02分,Coherus Biosciences, Inc.股票出现波动,股价急速上涨5.17%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为1.59%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523022296190ed7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523022296190ed7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2508457652","title":"Coherus Biosciences, Inc.盘中异动 急速拉升5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508457652?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:33","pubTimestamp":1738679605,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时33分,Coherus Biosciences, Inc.股票出现波动,股价快速拉升5.41%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.16%。其相关个股中,Azitra Inc、Evaxion Biotech As、Invivyd, Inc.涨幅较大,Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃,换手率分别为920.51%、691.29%、186.98%,振幅较大的相关个股有Azitra Inc、Invivyd, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为35.91%、19.81%、19.74%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223325a2392939&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223325a2392939&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2508996742","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508996742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508996742?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:24","pubTimestamp":1738340683,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日00时24分,Coherus Biosciences, Inc.股票出现异动,股价大幅下跌5.17%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为1.57%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502010024439614f89c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502010024439614f89c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2507620681","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.34%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507620681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507620681?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:53","pubTimestamp":1738252412,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时53分,Coherus Biosciences, Inc.股票出现异动,股价大幅拉升5.34%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.31%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302353329876bb35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302353329876bb35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2507254525","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大跌6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507254525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507254525?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:25","pubTimestamp":1738081508,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时25分,Coherus Biosciences, Inc.股票出现波动,股价大幅下跌6.47%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129002508abbb7dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129002508abbb7dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2506589813","title":"Coherus Biosciences, Inc.盘中异动 下午盘急速跳水5.24%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506589813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506589813?lang=zh_cn&edition=full","pubTime":"2025-01-28 03:05","pubTimestamp":1738004713,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日03时05分,Coherus Biosciences, Inc.股票出现异动,股价快速下跌5.24%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.91%。其相关个股中,Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、89Bio, Inc.涨幅较大,Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为2170.87%、1038.93%、260.35%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为108.60%、99.77%、65.16%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280305149874d7f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280305149874d7f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2505394861","title":"Coherus Biosciences, Inc.盘中异动 股价大涨5.08%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505394861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505394861?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:32","pubTimestamp":1737729136,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时32分,Coherus Biosciences, Inc.股票出现异动,股价快速上涨5.08%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。其相关个股中,Pmgc Holdings Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.涨幅较大,Evaxion Biotech As、Pmgc Holdings Inc.、Avenue Therapeutics, Inc.较为活跃,换手率分别为2026.32%、1178.79%、840.43%,振幅较大的相关个股有Pmgc Holdings Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.,振幅分别为26.26%、21.70%、21.20%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223217960f8d63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223217960f8d63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2505726604","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大涨6.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505726604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505726604?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:31","pubTimestamp":1737556267,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时31分,Coherus Biosciences, Inc.股票出现波动,股价大幅拉升6.89%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223107a22bb127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223107a22bb127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2505784614","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505784614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505784614?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:46","pubTimestamp":1737492386,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时46分,Coherus Biosciences, Inc.股票出现异动,股价急速跳水5.04%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为1.75%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122044627986e72ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122044627986e72ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2503267919","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503267919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503267919?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:46","pubTimestamp":1737042375,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时46分,Coherus Biosciences, Inc.股票出现波动,股价快速下挫5.14%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.69%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116234615abad616b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116234615abad616b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2503470376","title":"Coherus Biosciences, Inc.盘中异动 早盘大幅拉升5.56%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503470376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503470376?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951498,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分,Coherus Biosciences, Inc.股票出现波动,股价急速上涨5.56%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。其相关个股中,Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大,Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃,换手率分别为184.63%、51.92%、35.32%,振幅较大的相关个股有Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.、Onconetix, Inc.,振幅分别为12.00%、10.72%、9.31%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223138ababf22d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223138ababf22d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2503571247","title":"Coherus Biosciences, Inc.盘中异动 快速上涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503571247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503571247?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:37","pubTimestamp":1736865452,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时37分,Coherus Biosciences, Inc.股票出现异动,股价急速上涨5.44%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.19%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223733abaaae59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223733abaaae59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2501775530","title":"Coherus Biosciences, Inc.盘中异动 早盘大幅上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501775530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501775530?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:36","pubTimestamp":1736346963,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时36分,Coherus Biosciences, Inc.股票出现波动,股价急速拉升5.10%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.08%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223603a21a542e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223603a21a542e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.coherus.com","stockEarnings":[{"period":"1week","weight":0.0374},{"period":"1month","weight":-0.0902},{"period":"3month","weight":-0.0902},{"period":"6month","weight":-0.2014},{"period":"1year","weight":-0.5132},{"period":"ytd","weight":-0.1957}],"compareEarnings":[{"period":"1week","weight":-0.0096},{"period":"1month","weight":-0.0127},{"period":"3month","weight":-0.0139},{"period":"6month","weight":0.0541},{"period":"1year","weight":0.1695},{"period":"ytd","weight":0.0138}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Coherus Biosciences, Inc.于2010年9月在特拉华州注册成立。该公司是一家商业阶段的生物制药公司,专注于创新癌症治疗的研究、开发和商业化以及已获批准的生物类似物组合的商业化。该公司的战略是建立一个领先的免疫肿瘤专营权,其资金来自通过净销售美国食品和药物管理局批准的疗法的多元化组合所产生的现金。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.000743},{"month":2,"riseRate":0.454545,"avgChangeRate":0.005379},{"month":3,"riseRate":0.5,"avgChangeRate":0.031914},{"month":4,"riseRate":0.5,"avgChangeRate":-0.06174},{"month":5,"riseRate":0.5,"avgChangeRate":-0.005756},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013481},{"month":7,"riseRate":0.5,"avgChangeRate":0.086566},{"month":8,"riseRate":0.8,"avgChangeRate":0.10749},{"month":9,"riseRate":0.1,"avgChangeRate":-0.143671},{"month":10,"riseRate":0.3,"avgChangeRate":-0.071307},{"month":11,"riseRate":0.5,"avgChangeRate":0.013066},{"month":12,"riseRate":0.545455,"avgChangeRate":0.040313}],"exchange":"NASDAQ","name":"Coherus Biosciences","nameEN":"Coherus BioSciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.3","shortVersion":"4.31.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Coherus Biosciences,CHRS,Coherus Biosciences股票,Coherus Biosciences股票老虎,Coherus Biosciences股票老虎国际,Coherus Biosciences行情,Coherus Biosciences股票行情,Coherus Biosciences股价,Coherus Biosciences股市,Coherus Biosciences股票价格,Coherus Biosciences股票交易,Coherus Biosciences股票购买,Coherus Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}